Follow the MediWound Ltd. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €162.8m. The latest transaction was filed on 28 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Shmulik Hess. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
MediWound Ltd. is a company focused on developing innovative solutions for wound treatment. It is listed on the NASDAQ.